, Volume 122, Issue 2, pp 169–174 | Cite as

Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects

  • J. Dingemanse
  • M. Bury
  • P. Joubert
  • J. Bock
Original Investigation


In a double-blind, six-way crossover study the effects on psychomotor performance and memory of single doses of Ro 41-3696 (1, 3, 5 and 10 mg), a novel non-benzodiazepine partial agonist at the benzodiazepine receptor, zolpidem (10 mg) and placebo were compared after night-time administration to 12 healthy young male subjects. Psychomotor performance tests (tracking and attention as part of a standardized task battery) were conducted just before and at 1.5 and 8 h after drug intake. The memory test consisted of the recall of a list of 15 words at 8 h after drug intake which had been learned at 1.5 h after intake. At 1.5 h after drug intake 10 mg zolpidem induced markedly larger psychomotor effects than any dose of Ro 41-3696. The effects of 5 and 10 mg Ro 41-3696 and zolpidem were significantly greater than those of placebo (P < 0.05). The following morning, 8 h after drug intake, the slight residual effects of 5 and 10 mg Ro 41-3696 were statistically significantly greater than placebo, whereas zolpidem effects did not differ from placebo. The results of the memory test showed that learning as well as recall were most clearly impaired by zolpidem. An influence of Ro 41-3696 on these variables was not observed for doses up to 5 mg. In conclusion, Ro 41-3696 at all doses tested induced less effects on psychomotor performance and memory than 10 mg zolpidem at 1.5 h after intake. However, the effects of Ro 41-3696 appeared to be of longer duration.

Key words

Ro 41-3696 Zolpidem Psychomotor performance Memory Hypnotics Pharmacodynamics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ashton H (1994) Guidelines for the rational use of benzodiazepines — when and what to use. Drugs 48:25–40PubMedGoogle Scholar
  2. Balkin TJ, O'Donnell VM, Wesensten N, McCann U, Belenky G (1992) Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology 107:83–88CrossRefPubMedGoogle Scholar
  3. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ (1993) Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 13:100–106PubMedGoogle Scholar
  4. Boer LC, Wientjes CJE (1988) Assessment of psychological fitness. In: Aschenbrenner H (ed) Proceedings of the workshop on psychological fitness. NATO DS/A/DR 89:107, pp 1–11Google Scholar
  5. Dingemanse J (1995) Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci: 17:67–75CrossRefPubMedGoogle Scholar
  6. Dingemanse J, Bury M, Roncari G, Zell M, Gieschke R, Gaillard AWK, Odink J, Van Brummelen P (1995) Pharmacokinetics and pharmacodynamics of Ro 41-3696, a novel non-benzodiazepine hypnotic. J Clin Pharmacol: (in press)Google Scholar
  7. ECSC-EEC-EAEC (1994) Guidelines on psychotropic drugs for the EC. Eur Neuropsychopharmacol 4:61–77Google Scholar
  8. Fairweather DB, Kerr JS, Hindmarch I (1992) The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 43:597–601PubMedGoogle Scholar
  9. Gaillard AWK, Gruisen A, de Jong R (1988) The influence of antihistamines on human performance. Eur J Clin Pharmacol 35:249–253CrossRefPubMedGoogle Scholar
  10. Ghoneim MM, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72:926–938PubMedGoogle Scholar
  11. Gieschke R, Cluydts R, Dingemanse J, de Cock W (1994) Effects of bretazenil vs. zolpidem and placebo on experimentally-induced sleep disturbance in healthy volunteers. Methods Find Exp Clin Pharmacol 16:667–675PubMedGoogle Scholar
  12. Hindmarch I (1991) Residual effects of hypnotics: an update. J Clin Psychiatry 52 [Suppl]: 14–15Google Scholar
  13. Johnson LC, Chernik DA (1982) Sedative-hypnotics and human performance. Psychopharmacology 76:101–113CrossRefPubMedGoogle Scholar
  14. Jonas JM, Coleman BS, Sheridan AQ, Kalinske RW (1992) Comparative clinical profiles of triazolam versus other shorteracting hypnotics. J Clin Psychiatry 53 [12 Suppl.]: 19–31Google Scholar
  15. Langer SZ, Arbilla S, Scatton B, Niddam R, Dubois A (1988) Receptors involved in the mechanism of action of zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven Press, New York, pp 55–80Google Scholar
  16. Langtry HD, Benfield P (1990) Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40:291–313PubMedGoogle Scholar
  17. Lorizio A, Terzano MG, Parrino L, Cesana BM, Priore P (1990) Zolpidem: a double-blind comparison of the hypnotic activity and safety of a 10-mg versus 20-mg dose. Curr Ther Res 47:889–898Google Scholar
  18. Maczaj M (1993) Pharmacological treatment of insomnia. Drugs 45:44–55PubMedGoogle Scholar
  19. Martin JR, Moreau J-L, Jenck F, Widmer U (1994) Pharmacological profile of several quinolizinones acting as partial agonists at the benzodiazepine receptor. Neuropsychopharmacology 10, 3S [Part 2]: 170SGoogle Scholar
  20. Roehrs T, Merlotti L, Zorick F, Roth R (1994) Sedative, memory, and performance effects of hypnotics. Psychopharmacology 116:130–134CrossRefPubMedGoogle Scholar
  21. Scherschlicht R (1994) The quinolizinone hypnotic Ro 41-3696, a partial agonist at the flumazenil binding site, induces EEG sleep in rabbits but lacks sedative side effects in rodents. 8. Biennial IPEG meeting, Berlin, GermanyGoogle Scholar
  22. Schoch P, Moreau JL, Martin JR, Haefely WE (1993) Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence. Biochem Soc Symp 59:121–134PubMedGoogle Scholar
  23. Shiffrin RM, Schneider W (1977) Controlled and automatic human information processing. II. Perceptual learning, automatic attending, and a general theory. Psychol Rev 84:127–190CrossRefGoogle Scholar
  24. Sternberg S (1969) Mental processes revealed by reaction time experiments. Am Sci 4:421–457Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • J. Dingemanse
    • 1
  • M. Bury
    • 1
  • P. Joubert
    • 1
  • J. Bock
    • 2
  1. 1.Department of Clinical PharmacologyF. Hoffmnn-La Roche LtdBaseSwitzerland
  2. 2.Department of BiostatisticsF. Hoffmnn-La Roche LtdBaselSwitzerland

Personalised recommendations